[Solved] Why is psychedelic therapy expensive?

At Triptherapie, we notice that psychedelic therapy can currently still be offered at a relatively affordable price, especially when compared to fully regulated medical treatments, such as those recently implemented in countries like Australia. However, it is important to realize that the price you pay now largely depends on the deployment of well-trained and committed staff. As the quality and expertise of the practitioners increase, costs naturally rise as well. But that investment often pays off in a better treatment plan, deeper insights, and more sustainable results for you as a client. Particularly when you consider that we invest an average of 8-10 hours per psychedelic session, the prices are reasonable and the hourly rate is below market rate.

Furthermore, our sessions include careful preparation, expert guidance during the session, and post-session integration. Facilitators who, in addition to experience, have also completed training in psychology, coaching, or neurochemistry offer richer and more effective support. This is reflected in the depth of the sessions and in the conversion of insights into lasting behavioral change.

If we look at medical psychedelic therapy as it is currently being rolled out in Australia, we see that treatment programs there quickly cost between €12,000 and €18,000. This includes three psychedelic sessions within a program. Converted, this amounts to €4,000-6,000 per session plus a number of therapy sessions without psychedelics. With Triptherapie, which is under €1,000, it is currently still 6-10 times cheaper. The higher costs are primarily the result of a medical framework, such as working with multiple therapists, medical screening, pharmaceutical agents, and mandatory protocols. In the long term, such a model could also come to Europe. The expectation is that more people will then be entitled to reimbursement through their health insurance. Thanks to health insurance coverage, the client would then pay more or less themselves, but the extra costs would be borne by the collective through the premium.

For those who find it interesting: The costs of a future regulated psychedelic program in the Netherlands will most likely consist of three dosing days with MDMA or psilocybin, two supervising therapists and 20 psychotherapy sessions without psychedelics. In our opinion, the estimated price is then €25,000.

For the time being, at Triptherapie you can benefit from small-scale, professional psychedelic therapy with personal attention, at a price that is still significantly lower than in the regulated medical circuit. We continue to invest in the quality of our counselors and in keeping this form of therapy accessible to a broad group of people.

See also: The Psychedelic session rates

Psychedelic therapy – whether involving truffles, LSD, ketamine, or MDMA analogues – entails significant costs. In this report, we examine the breakdown of these costs, with examples of Triptherapie (a Dutch provider of psychedelic sessions) and we compare that with the rates in regulated medical settings like Australia. We will see that the hours of supervising therapists and location costs, in particular, are the largest components, and that strict medical environments can drive the price up even further.

Costs at Triptherapie in the Netherlands (private sessions and ceremonies)

At Triptherapie Psychedelic sessions are offered outside the regular medical circuit. The rates may seem high at first glance, but they include a complete process from intake to aftercare. Some examples of current price indications:

1. Open group ceremonies: Participation in an open truffle ceremony costs approximately €650 per person. This includes everything What is needed for a safe and comfortable experience: preparation advice, the guided psychedelic ceremony itself, food and drinks, an overnight stay on-site, and a follow-up integration session. (For example, Triptherapie organizes truffle ceremonies for up to 6 participants at €650 pp, and MDMA group sessions for €650 with a maximum of 5 participants.)

2. Individual private sessions: A one-on-one psychedelic session of approximately 6 hours with a personal tripsitter/therapist usually costs between €750 and €950. This price depends on the chosen accompanist (their level of experience) and the location. Triptherapie uses three categories: a less experienced facilitator (~€750), a medium experienced therapist (~€850), and a highly experienced therapist (~€950) for a single session. Higher rates apply for duo sessions with two participants (e.g., ~€1,250 in the lowest category for two people).

3. Location costs: If the session at home or takes place at your own location, Triptherapie only charges a small travel allowance (approx. €0.50 per km) and no additional location fee. If the session takes place at the Psychedelic Loft in Schiedam (their own specialized location), then there comes €400 venue rental included. In exchange, an overnight stay at the location and all meals/drinks are included. This structure clearly shows that especially the space and facilities be a significant expense for private sessions.

What is included? The rates at Triptherapie are “all-inclusive” for the entire journey. According to the provider, the costs include, among other things:

1. extensive preparation (personal advice after an intake and practical tips beforehand),

2. guidance by an expert therapist/tripsitter during the session,

3. use of all necessary materials (e.g. psychedelic truffles or other substances, aromatherapy, etc.),

4. possibly catering and accommodation at ceremonies on location,

5. and aftercare with an integration conversation to process the experience.

In other words, one pays not only for the remedy itself, but primarily for the professional service and the safe framework surrounding it. For example, a truffle dose or LSD analogue is usually worth only a few tens of euros, but the six to seven hours of intensive guidance by a therapist is where the bulk of the price lies. Triptherapie explicitly states that their session price covers these ~6 hours of guidance, and in the event of any overrun exceeding an hour, an hourly rate (€75–€100) is added – this illustrates that staff time expenditure forms the core of the cost. Moreover, Triptherapie differentiates pricing based on the counselor's experience, which indicates that expertise of the staff is an important part of the value (and costs).

Important: Because psychedelic therapy (such as truffle or LSD sessions) no recognized regular treatment is in the Netherlands, this becomes not reimbursed for the time being by health insurers. The client therefore pays the costs entirely themselves. (Triptherapie has set up its own fund to offer discounts on group ceremonies to people with lower incomes, which indicates that the price constitutes a barrier for some target groups.)

Costs in regulated medical settings (example: Australia)

A therapy room for psychedelic sessions with a comfortable seating and reclining area. In medical settings (such as clinics), clients are treated in a calming environment, often for several hours under the supervision of two therapists.

In countries like Australia has recently begun regulating psychedelic therapy within strict medical frameworks. This means that treatments only take place under the supervision of certified psychiatrists and psychologists and often make use of pharmaceutical (synthesized) versions of the substances. This has the potential to increase effectiveness, but it The price tag is even higher than with non-medical sessions.

For example, the first psychedelic clinic opened in Melbourne in 2023 (Clarion Clinic), offering a complete treatment package for depression or PTSD. approximately $24,000 AUD cost for a nine-month program. This sum covers all medical consultations, preparatory sessions, one or more dosing sessions with the substance (psilocybin or MDMA), and the subsequent psychotherapy sessions over that period. Another provider estimates the total cost for a standard program at $20,000–$30,000 AUD, what if ""prohibitive"" (prevents a very large number of patients) is seen. By way of comparison: this amounts to roughly €12,000–€18,000 euros. Why so high? Especially due to the intensive guidance: a typical series of treatments can consist of multiple dosing days whereupon the patient ingests the psychedelics in the presence of two professional therapists at the same time, plus many hours of pre- and post-care sessions. In one Australian program, each dosing session lasts approximately 8 hours with 2 therapists present, and this becomes three repeated times during a 12- to 16-week treatment. Those dosing days alone represent 3×8×2 = 48 hours of therapist work, not including individual preparatory consultations, evaluations, and medical screenings. It is clear that personnel costs here mount up enormously.

Moreover, treatments in a medical context must comply with various safety and quality requirements. There is usually a psychiatrist involved who supervises the sessions (and who charges a high hourly rate), there are medical precautions (for example, a doctor or nurse on standby, emergency equipment) and the means themselves must be of pharmaceutical quality. pharmaceutical psychedelics (e.g. pure psilocybin capsules or medical MDMA) are more expensive than natural truffles or pharmacy ketamine. They are often produced specifically for research/therapy and can have a high price per dose due to patent protection or small-scale production.

An important difference with the Netherlands is that in Australia these treatments recently are allowed for specific patients, but not yet reimbursed by the public healthcare system. There is no structural subsidy or insurance to cover the costs. As Australian experts indicate, the intensive nature of the therapy combined with the lack of reimbursement means that the costs run into the many thousands of dollars, which makes it unaffordable for most people. Only very recently has a single private health insurer started reimbursing psychedelic therapy on a trial basis for certain clients, but for the time being, virtually everyone has to pay for it out of pocket.

Where do most of the costs lie?

Given the examples above, we can conclude that the main cost items in psychedelic therapy are as follows:

1. Therapist(s) and supervisors: By far the largest part of the costs goes towards the time and expertise of the professionals who conduct the sessions. Psychedelic therapy is labor-intensive – a single session easily takes half to a full workday, often with two therapists present simultaneously in medical settings. The hours spent on intake interviews and subsequent integration also count. At Triptherapie, we see this reflected in the price differences based on facilitator experience (experienced therapists cost more). In clinical trials, a therapy duo is usually used for optimal support, which doubles labor costs.

2. Location and facilities: The setting must be safe, comfortable, and low-stimulus. This may mean that sessions take place in specially equipped rooms or clinics. Renting or furnishing such a space and potential overnight accommodation entails costs. In the Netherlands, for example, Triptherapie charges an additional €400 for the use of their own location, including accommodation, whereas a home-based session does not incur these costs. In medical clinics, the rooms are often furnished like a quasi-living room but within a hospital-like infrastructure, which also generates overhead costs (rent, maintenance, equipment).

3. Pre- and post-care (process costs): High-quality psychedelic therapy encompasses more than just the “trip” itself. Resources and time are devoted to screening for contraindications (certainly in a medical context, this requires doctor visits and potentially medical tests), preparation sessions to align the patient’s intention and mindset, and multiple integration therapies after the trip to process the insights. All these components are part of the process and are included in the price (as Triptherapie explicitly states for their packages). They sometimes extend the treatment process over months, requiring the patient to return regularly—resulting in more hours that need to be reimbursed.

4. Psychedelic substances themselves: Interestingly, the substances (truffles, LSD, MDMA, ketamine, etc.) generally constitute the smallest cost item. In the “underground” or semi-legal setting, truffles are legally and cheaply available, and LSD/MDMA analogues are used in minimal quantities. In the medical context, the costs of the substances can turn out to be slightly higher (pharmaceutical production is more expensive; for instance, a dose of esketamine nasal spray or intravenous ketamine easily costs hundreds of euros). Nevertheless, these costs are relatively modest compared to personnel and logistical expenses.

5. Medical supervision and regulation: This is specific to regulated therapy. Complying with all protocols and safety requirements can entail additional costs – think of the presence of a doctor or nurse, emergency planning, insurance/liability, and administrative burdens to comply with regulations. These “invisible” costs make therapy in, for example, an Australian clinic more expensive than an informal retreat in the Netherlands.

In summary, psychedelic therapy is therefore expensive because it is a intensive, personalized treatment which requires a great deal of professional time and care in a specially created setting. In the Netherlands, we see that the price lies primarily in the deployment of qualified therapists/trip sitters and the organization of a suitable space for the session. In fully medical settings (such as in Australia or at ketamine clinics), additional factors are added on top of this – higher hourly rates for specialists, expensive patented medicines, and stricter (costly) protocols – causing total costs to rise even further. As long as most insurers do not reimburse this, these programs remain a significant investment for the individual client. Nevertheless, providers justify the costs with the argument that the intensive guidance is crucial for effective and safe results – something you pay for in such long-term processes.

Sources: The prices and information used are from Triptherapie (Netherlands) triptherapie.nl triptherapie.nl triptherapie.nl, news sources about Australian clinics theguardian.com abc.net.au, and reports from medical experts abc.net.au who explain the current cost structure of psychedelic therapy.

When you consider the number of hours of expensive healthcare staff involved, the price is indeed high, but cheaper than what you currently pay per hour to a psychologist. And if the effectiveness is also much higher, successful psychedelic therapy might well save thousands of euros on psychotherapy. In the long run, therefore, psychedelic-assisted therapy could actually be cheaper.

At Triptherapie, the price is not that high at all. Of course, 600-1,000 euros is a significant expense, but compared to other providers and the thorough approach, it is really quite reasonable and actually rather cheap.

Wonderful overview from Marcel and Research with that detailed cost analysis! This really gets to the heart of the matter. I would like to add a few points here based on the current market.

As Marcel and Research very rightly point out: the major cost lies in therapeutic hours, not in the substances themselves. Psilocybin in truffle form truly costs tens of euros, MDMA powder perhaps the same. The six to eight hours of intensive guidance, on the other hand? That is real work.

What is interesting is that psychedelic therapy is increasingly being compared to the gold standard PTSD treatment, namely prolonged exposure therapy (PET). That costs approximately 1,500–3,000 euros for 12–16 sessions of one hour each. One psychedelic session costs 750–1,000 euros, but often covers more ground in one day than weeks of conventional therapy. This makes the effectiveness per hour much higher.

The reason prices in the Netherlands are relatively low compared to Australia? Many Dutch providers operate in a legal grey area. They are not required to adhere to the same medical protocols. This limits oversight costs. As soon as psychedelic therapy is regulated in Europe, prices will rise due to stricter regulations, medical screening, insurance, and oversight.

Olaf and Marion are also right: in the long run, one successful psychedelic session saves you thousands of euros in traditional therapy, medication, and hospital costs. The question is not whether it is expensive, but whether it is more effective than the current alternative.

My forecast: in 3-5 years, Dutch clinics will scale closer to 2,000-3,000 euros per session when regulation comes into effect, but this will be reimbursed by health insurers for specific diagnoses. That will ultimately make it cheaper per person due to collective coverage.

A good point to add: the costs also depend heavily on the provider's business model. Companies operating on a smaller scale and lacking hospital-like infrastructure can indeed operate much more cheaply than fully digitized medical clinics.

What many people do not realize is how much preparation is actually required for safety. A therapist must conduct thorough screening interviews, check for contraindications (psychiatric history, medication use, heart conditions), and assess psychological state. All of this takes hours per client. The point is that psychedelics have strong neurochemical effects—they activate serotonin receptors in ways that can cause unforeseen interactions with certain medications or conditions.

The aftercare phase is equally crucial. Much of the therapeutic value lies in integration—how you translate the insights from your trip into concrete behavioral change. This often requires multiple integration sessions, not just a short follow-up. Researchers in America have noted that clients who receive good integration guidance achieve far more lasting benefits than those who leave it to chance.

From an economic perspective, it is also interesting: many insurers should actually be pleased with psychedelic therapy. If someone has a PTSD diagnosis, traditional trauma therapy can take months or years with uncertain outcomes. A successful psychedelic session can achieve more in one day than twelve months of conventional therapy. The societal savings could therefore be substantial—fewer lost workdays, less medication use, fewer hospital admissions due to comorbidity. This makes psychedelic therapy expensive for the individual for the time being, but actually very cost-effective for the collective.

When regulation comes—and all signs point to this happening in Europe in the coming years—it will likely initially increase costs (more administration, oversight, expensive protocols), but at the same time open the way to reimbursement. That could ultimately make it accessible to many more people.